侵袭性念珠菌病的抗原抗体检测进展

摘要/Abstract

中图分类号:

R446.53

陈玲, 王红. 侵袭性念珠菌病的抗原抗体检测进展[J]. 中国真菌学杂志, 2013, 8(5): 316-320.

[1] Jose Sifuentes-Osornio,Dora E. Epidemiology of Invasive Fungal Infections in Latin[J].Curr Fungal Infect Rep,2012,6(1): 3-34.
[2] Ma CF, Li FQ, Shi LN,et al.Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China[J].BMC Infect Dis,2013,13: 337.
[3] Yap HY,Kwok KM,Gomersall CD,et al. Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong[J].Hong Kong Med J,2009,15(4):255-261.
[4] Pemán J, Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings[J]. Mycoses,2010,53(5):424-433.
[5] Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies[J]. Clin Microbiol Infect Dis,2006,25(7): 419-425.
[6] Marchetti O,Lamoth F,Mikulska M,et al.ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients[J]Bone Marrow Transplant,2012,47(6):846-854.
[7] Lamoth F,Cruciani M,Mengoli C, et al.Third European Conference on Infections in Leukemia (ECIL-3) (2012) β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).[J]Clin Infect Dis,2012, 54(5):633-643.
[8] 郭云武. 血浆1,3-β-D-葡聚糖诊断侵袭性真菌感染的meta分析[J]. 中国卫生检验杂志,2013,23(2):483-486.
[9] Karageorgopoulos DE, Vouloumanou EK, Ntziora F,et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis[J]. Clin Infect Dis,2011,52(6):750-770.
[10] Onishi A, Sugiyama D, Kogata Y,et al. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis[J]. Clin Microbiol,2012,50(1):7-15.
[11] Lamoth F, Cruciani M, Mengoli C etal.β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference onInfections in Leukemia (ECIL-3)[J].Clin Infect Dis,2012,54(5):633-643.
[12] Usami M, Ohata A, Horiuchi T etal.Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing[J]. Transfusion,2002,42(9):1189-1195.
[13] Mohr JF, Sims C, Paetznick V,et al. Prospective survey of (1,3)-β-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting[J]. Clin. Microbiol,2011,49(1):58-61.
[14] Posteraro B, De Pascale G, Tumbarello M,et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1,3)-β-d-glucan assay,Candida score, and colonization index[J]. Crit Care,2011,15(5):249.
[15] Acosta J, Catalan M, del Palacio-Pérez-Medel A,et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-d-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease[J].Clin.Microbiol.Infect. Dis,2012,31(5):721-731.
[16] Cuenca-Estrella M,Verweij PE,Arendrup MC,et al.ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures[J].Clin Microbiol Infect,2012, 18 (Suppl 7):9-18.
[17] Sims CR, Jaijakul S, Mohr J,et al. Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis[J]. Clin Microbiol.2012,50(6):2104-2106.
[18] Yang GH, Sheng ZY. The value of assay of (1, 3)-β-D-glucan in bronchoalveolar lavage fluid for detection of invasive pulmonary fungal infection in critically ill patients in intensive care unit[J].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue,2012,24(2):90-95.
[19] De Pauw B, Walsh TJ, Donnelly JP,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group[J]. Clin Infect Dis,2008,46(12):1813-1821.
[20] Sendid B, Poirot JL, Tabouret M,et al.Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species[J].Med Microbiol,2002,51(5):433-442.
[21] Prella M, Bille J, Pugnale M,et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies[J]. Diagn Microbiol Infect Dis,2005,51(2):95-101.
[22] Pemán J, Zaragoza R. Combined Use of Nonculturebased Lab Techniques in the Diagnosis and Management of Critically ill Patients with Invasive Fungal Infections[J].Expert Rev Anti Infect Ther, 2012,10(11):1321-1330.
[23] Sun HY, Chiu YS, Tang JL,et al. The usefulness of the Platelia Candida antigen in a patient with acute lymphocytic leukemia and chronic disseminated candidiasis[J].Med Mycol,2006,44(7):647-650.
[24] Caggiano G, Puntillo F, Coretti C,et al.Candida colonization index in patients admitted to an ICU[J].Int J Mol Sci, 2011,12(10):7038-7047.
[25] Verduyn Lunel FM, Donnelly JP,et al.Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy[J].Clin Microbiol Infect,2009,15(4):380-386.
[26] Mikulska M, Calandra T, Sanguinetti M,et al.The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia[J].Crit Care,2010,14(6):222.
[27] Laín A, Moragues MD, Ruiz JC,et al. Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis[J]. Clin. Vaccine Immunol,2007,14(3),318-319.
[28] Pitarch A, Jiménez A,et al.Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: Analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms[J].Proteomics Clin Appl, 2008,2(4):596-618.
[29] Pitarch A, Jiménez A, Nombela C,et al.Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by Proteomic and bioinformatic analyses[J]. Mol Cell Proteomics,2006,5(1):79-96.
[30] Li Wq, Hu Xc, Zhang,et al.Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice[J].Vaccine,2011,29(33):5526-5533.
[31] Held J, Kohlberger I,et al.Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia[J].Clin Microbiol,2013,51(4):1158-1164.
[32] Takazono T, Izumikawa K,et al.Evaluation of the Cica Fungi Test Candida, a novel serum Candida mannan antigen kit, and its comparison with Cand-Tec in candidemia patients[J].Jpn J Infect Dis,2011,64(2):116-120.
[33] Misaki H, Iwasaki H, Ueda T.A comparison of the specificity and sensitivity of two Candida antigen assay systems for the diagnosis of deep candidiasis in patients with hematologic diseases[J].Med Sci Monit,2003,9(2):MT1-7.
[34] Bär W, Hecker H.Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies[J].Mycoses,2002,45(1-2):22-28.
[35] Ibàñez-Nolla J, Torres-Rodríguez JM,et al.The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients[J].Mycoses,2001,44(1-2):47-53.
[36] Zaragoza R, Pemán J, Quindós G,et al. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients[J]. Clin Microbiol Infect,2009;15(6):592-595.
[37] Quindós G, Moragues MD, Pontón J. Is there a role for antibody testing in the diagnosis of invasive candidiasis[J]? Rev Iberoam Micol,2004,21(1):10-14.
[38] Maertens J, Buvé K, Theunissen K,et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients[J]. Cancer,2009,115(2),355-362.
[39] Moragues MD, Ortiz N, Iruretagoyena JR,et al. Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis[J]. Enferm Infecc Microbiol Clin 2004,22(2): 83-88.
[40] Zaragoza R, Pemán J, Ramirez P,et al. Clinical and management utility of Candida germ tube antibody detection in critically ill patients.Preliminary data 46 th Interscience Conference on Antimicrobial Agents and Chemotherapy: San Francisco, CA, 2006(Abstract M-1618).
[41] Zaragoza R, Pemán J, Quindós G,et al. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality[J].Clin.Vaccine Immunol,2009,16(10),1527-1528.
[42] Pemán J, Zaragoza R, Quindós G,et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients[J]. BMC Infect. Dis,2011,11(1):60.
[43] Damiens S, Poissy J, François N,et al.Mannose-binding lectin levels and variation during invasive candidiasis[J].Clin Immunol,2012,32(6):1317-1323.
[44] Gropp K, Schild L, Schindler S, et al.The yeast Candida albicans evades human complement attack by secretion of aspartic proteases[J].Mol Immunol, 2009,47(2-3):465-475.
[45] Quanping S, Yanyan H, Yicun W, et al.The use of hybrid phage displaying antigen epitope and recombinant protein in the diagnosis of systemic Candida albicans infection in rabbits and cancer patients[J].Diagn Microbiol Infect Dis,2010,68(4):382-389.
[46] Laín A, Moragues MD, Ruiz JC,et al. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1[J].Clin Vaccine Immunol,2007,14(3),318-319.
[47] Clancy CJ, Nguyen ML, Cheng S,et al. Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis[J].Clin microbiol,2008,46(5),1647-1654.
[48] Philip A, Odabasi Z, Matiuzzi G,et al.Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis[J].Clin Microbiol,2005,43(9):4834-4835.

侵袭性念珠菌病的抗原抗体检测进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张静云, 彭靖雯, 王琼, 高盈, 陈万鑫, 沈永年, Li Dong-mei, 佘晓东, 刘维达. 表皮生长因子受体在阴道念珠菌病发病过程中的作用初探[J]. 中国真菌学杂志, 2020, 15(2): 65-71.
[2]	阚思玥, 蔡晴, 金云, 陈伟, 胡素泉, 杨连娟, 刘维达. 婴幼儿皮肤黏膜念珠菌病临床特点及其病原菌体外药敏分析[J]. 中国真菌学杂志, 2020, 15(2): 97-100.
[3]	黄进宝, 李红艳, 兰长青, 吕骁, 林志来, 王新航, 张宏英, 邹盛华, 翁恒. 两种血清隐球菌荚膜多糖抗原检测方法在肺隐球菌病中的应用研究[J]. 中国真菌学杂志, 2019, 14(5): 264-269.
[4]	王钰婷, 王玉柱, 刘锦燕, 孟玲宁, 李卫华, 项明洁. 酵母相和菌丝相白念珠菌感染阴道上皮细胞免疫反应的比较[J]. 中国真菌学杂志, 2019, 14(4): 193-199.
[5]	刘道凡, 伍启康. 日舒安洗液联合克霉唑治疗小鼠外阴阴道念珠菌病的疗效观察[J]. 中国真菌学杂志, 2019, 14(1): 32-36.
[6]	隋雪, 姜远英, 阎澜. 白念珠菌细胞壁蛋白Csp37抗原表位预测[J]. 中国真菌学杂志, 2018, 13(6): 327-334.
[7]	侯欣, 徐英春, 赵玉沛. 棘白菌素在念珠菌中的耐药性[J]. 中国真菌学杂志, 2018, 13(1): 40-45.
[8]	晏亮, 邓淑文, 潘炜华, 廖万清. 我国外阴阴道念珠菌病致病菌菌种分布及体外药敏研究现状[J]. 中国真菌学杂志, 2018, 13(1): 46-52.
[9]	童建波, 曾荣, 李岷. 烟曲霉生物膜研究进展[J]. 中国真菌学杂志, 2018, 13(1): 61-64.
[10]	范瑞强, 袁娟娜. 复发性外阴阴道念珠菌病中西医结合治疗专家共识[J]. 中国真菌学杂志, 2017, 12(6): 325-327,324.
[11]	段强军, 云云, 陈志珍, 邵菁, 汪天明, 汪长中. 白头翁汤正丁醇提取物对小鼠外阴阴道念珠菌病的治疗作用研究[J]. 中国真菌学杂志, 2017, 12(6): 337-341.
[12]	郭爽, 刘意, 田小军, 栗绍刚, 宋营改, 任翊. HIV感染和非HIV感染人群抗耶氏肺孢子菌主要表面糖蛋白的IgG和IgM抗体水平调查[J]. 中国真菌学杂志, 2017, 12(6): 342-345.
[13]	晏亮, 邓淑文, 张东兴, 潘炜华, 廖万清. 外阴阴道念珠菌病病原菌对11种抗真菌药物体外敏感性分析[J]. 中国真菌学杂志, 2017, 12(6): 356-358.
[14]	邱璐瑶, 平静, 李文道, 丁嵩涛, 刘含登. 3种微孢子虫在我国西南部分地区腹泻患者中的流行情况调查[J]. 中国真菌学杂志, 2017, 12(5): 257-261.
[15]	谭静文, 何文婧, 高志琴, 杨虹, 章楚光, 梁豫琳, 杨连娟. IL-22对口腔白念珠菌感染的保护作用及机制研究[J]. 中国真菌学杂志, 2017, 12(4): 207-211.